He points to a 2025 otolaryngology study that tracked patients losing significant weight on GLP-1s and measured facial changes per 10 kg lost.
Recap by typeshit. Post by @omarhussainmd on Instagram.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Medscape reports the finding on nail separation in GLP-1 users. Experts quoted call for more research and caution doctors against alarming patients.
A look at how targeted peptides taken by mouth can survive the gut and still reach specific sites in the body. Details are in the full story.
Loading…